Al-Makki A, DiPette D, Whelton PK, Murad MH, Mustafa RA, Acharya S, et al. Hypertension pharmacological treatment in adults: a World Health Organization Guideline Executive Summary. Hypertension. 2022;79(1):293–301.

Article  CAS  PubMed  Google Scholar 

Hinton TC, Adams ZH, Baker RP, Hope KA, Paton JFR, Hart EC, et al. Investigation and treatment of high blood pressure in Young People. Hypertension. 2020;75(1):16–22.

Article  CAS  PubMed  Google Scholar 

Nadar SK, Lip GYH. The heart in hypertension. J Hum Hypertens. 2021;35(5):383–6.

Article  PubMed  Google Scholar 

Yildiz M, Oktay AA, Stewart MH, Milani RV, Ventura HO, Lavie CJ. Left ventricular hypertrophy and hypertension. Prog Cardiovasc Dis. 2020;63(1):10–21.

Article  PubMed  Google Scholar 

Bhullar SK, Dhalla NS. Angiotensin II-Induced Signal Transduction mechanisms for Cardiac Hypertrophy. Cells. 2022;11(21):3336.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ahmed SN, Jhaj R, Sadasivam B, Joshi R. The role of renin–angiotensin–aldosterone system inhibition in the regression of hypertensive left ventricular hypertrophy: the evidence of the last three decades. Drugs Therapy Perspect. 2020;36(11):509–17.

Article  Google Scholar 

Shi F, Collins S. Regulation of mTOR Signaling: emerging role of cyclic nucleotide-dependent protein kinases and implications for Cardiometabolic Disease. Int J Mol Sci. 2023;24(14):11497.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Das A, Reis F. mTOR Signaling: New insights into Cancer, Cardiovascular diseases, Diabetes and Aging. Int J Mol Sci. 2023;24(17):13628.

Article  PubMed  PubMed Central  Google Scholar 

Wang C, Yuan Y, Zheng M, Pan A, Wang M, Zhao M, et al. Association of Age of Onset of Hypertension with Cardiovascular diseases and Mortality. J Am Coll Cardiol. 2020;75(23):2921–30.

Article  PubMed  Google Scholar 

Sinha MD, Azukaitis K, Sladowska-Kozłowska J, Bårdsen T, Merkevicius K, Karlsen Sletten IS, et al. Prevalence of left ventricular hypertrophy in children and young people with primary hypertension: Meta-analysis and meta-regression. Front Cardiovasc Med. 2022;9:993513.

Article  PubMed  PubMed Central  Google Scholar 

Altaweel RB, Radhi MA. Assessment of Left ventricular hypertrophy (LVH) criteria by Surface Electrocardiography in a sample of Iraqi patients with systemic arterial hypertension. Med Archives. 2020;74(6):428.

Article  Google Scholar 

Kristensen CB, Steensgaard-Hansen F, Myhr KA, Løkkegaard NJ, Finsen SH, Hassager C et al. Left ventricular Mass Assessment by 1- and 2-Dimensional echocardiographic methods in Hemodialysis patients: changes in left ventricular volume using Echocardiography before and after a Hemodialysis Session. Kidney Med.2020; 2(5): 578–88.

Martins J, Steyn N, Rossouw HM, Pillay TS. Best practice for LDL-cholesterol: when and how to calculate. J Clin Pathol. 2023;76(3):145–52.

Article  CAS  PubMed  Google Scholar 

Bornstein AB, Rao SS, Marwaha K, Left Ventricular H. 2023 Aug 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 32491466.

Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH guidelines for the management of arterial hypertension the Task Force for the management of arterial hypertension of the European Society of Hypertension. J Hypertens. 2023;41(12):1874–2071.

Article  CAS  PubMed  Google Scholar 

Lee H, Yano Y, Cho SMJ, Park JH, Park S, Lloyd-Jones DM, et al. Cardiovascular Risk of isolated systolic or diastolic hypertension in young adults. Circulation. 2020;141(22):1778–86.

Article  PubMed  Google Scholar 

Meher M, Pradhan S, Pradhan SR. Risk factors Associated with hypertension in young adults: a systematic review. Cureus. 2023;15(4):e37467.

PubMed  PubMed Central  Google Scholar 

Bouffette S, Botez I, De Ceuninck F. Targeting galectin-3 in inflammatory and fibrotic diseases. Trends Pharmacol Sci. 2023;44(8):519–31.

Article  CAS  PubMed  Google Scholar 

Sygitowicz G, Maciejak-Jastrzębska A, Sitkiewicz D. The diagnostic and therapeutic potential of galectin-3 in cardiovascular diseases. Biomolecules. 2021;12(1):46.

Article  PubMed  PubMed Central  Google Scholar 

Cunha CL. Electrocardiographic diagnosis of left ventricular hypertrophy. Arquivos brasileiros de cardiologia. 2021;117:932–3.

Article  PubMed  Google Scholar 

Cuspidi C, Sala C, Negri F, Mancia G, Morganti A. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies. J Hum Hypertens. 2012;26(6):343–9.

Article  CAS  PubMed  Google Scholar 

Hussein M, Muyinda A, Olet SC, Hersi AM, Said AI, Elmi HSA. Prevalence rate of left ventricular hypertrophy and the burden of arrhythmias among hypertensive patients attending Jinja regional referral hospital, eastern Uganda. Curr Probl Cardiol. 2024;49(7):102576.

Article  PubMed  Google Scholar 

Apitz A, Socrates T, Burkard T, Mayr M, Vischer AS. Prevalence and characterisation of severe left ventricular hypertrophy diagnosed by echocardiography in hypertensive patients. J Clin Med. 2022;12(1):228.

Article  PubMed  PubMed Central  Google Scholar 

Ogunlade O, Akintomide AO. Assessment of voltage criteria for left ventricular hypertrophy in adult hypertensives in south-western Nigeria. J Cardiovasc Dis Res. 2013;4(1):44–6.

Article  PubMed  PubMed Central  Google Scholar 

Ngabea MA, Ojji DB, Umar H, Isezuo SA. Prevalence of echocardiographic left ventricular hypertrophy among hypertensives in a tertiary health institution in Nigeria. Ann Med Res Pract. 2022;3(3):1–5.

Google Scholar 

Amidou SA, Houehanou YC, Gbaguidi GN, Lacroix P, Aboyans V, Sonou A, et al. Normal limits of electrocardiogram in africans and their consequences on the prevalence of left ventricular hypertrophy in hypertensive individuals: insights from the TAHES study. J Electrocardiol. 2023;76:71–8.

Article  PubMed  Google Scholar 

Salamaga S, Juszczyk I, Dydowicz F, Matyjasek M, Turowska A, Lipski D, et al. Evaluation of sensitivity and specificity of ECG left ventricular hypertrophy criteria in obese and hypertensive patients. Arterial Hypertens. 2023;27(4):223–31.

Article  Google Scholar 

Sundström J, Lind L, Vessby B, Andrén B, Aro A, Lithell HO. Dyslipidemia and an unfavorable fatty acid Profile Predict Left ventricular hypertrophy 20 years later. Circulation. 2001;103(6):836–41.

Article  PubMed  Google Scholar 

Huang X, Deng K, Qin J, Lei F, Zhang X, Wang W, Lin L, Zheng Y, Yao D, Lu H, Liu F. Association between lipid profiles and left ventricular hypertrophy: new evidence from a retrospective study. Chin Med Sci J. 2022;37(2):103–17.

Article  CAS  PubMed  Google Scholar 

Ikeda S, Shinohara K, Tagawa K, Tohyama T, Kishimoto J, Kazurayama M, Tanaka S, Yamaizumi M, Nagayoshi H, Toyama K, Matsushima S. Association of baseline electrocardiographic left ventricular hypertrophy with future renal function decline in the general population. Sci Rep. 2024;14(1):301.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nardi E, Mulè G, Giammanco A, Mattina A, Geraci G, Nardi C, et al. Left ventricular hypertrophy in chronic kidney disease: a diagnostic criteria comparison. Nutr Metabolism Cardiovasc Dis. 2021;31(1):137–44.

Article  Google Scholar 

Stanciu S, Rusu E, Miricescu D, Radu AC, Axinia B, Vrabie AM, et al. Links between metabolic syndrome and hypertension: the relationship with the current antidiabetic drugs. Metabolites. 2023;13(1):87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dorobantu M, Vîjîiac A. Myocardial ischemia: a link between hypertension and heart failure. InHypertension and Heart failure: Epidemiology, mechanisms and Treatment 2024 Mar 5 (pp. 155–67). Cham: Springer International Publishing.

Oldfield CJ, Duhamel TA, Dhalla NS. Mechanisms for the transition from physiological to pathological cardiac hypertrophy. Can J Physiol Pharmacol. 2020;98(2):74–84.

Article  CAS  PubMed  Google Scholar 

Macvanin MT, Rizzo M, Radovanovic J, Sonmez A, Paneni F, Isenovic ER. Role of chemerin in cardiovascular diseases. Biomedicines. 2022;10(11):2970.

Article  CAS  PubMed